CLEVELAND — The Cleveland Clinic has recently shared their research that provides insight into how the immune system protects the body after a confirmed COVID-19 infection.
The study followed its caregivers over five months as the vaccination process was beginning. The data showed that the vaccine was highly effective in preventing COVID-19 infection.
In addition, the study found that none of the previously infected employees who remained unvaccinated were re-infected throughout the study. This information could help guide vaccination efforts should there be a shortage of vaccine supply and in countries where vaccine supply is limited.
The clinic understands that further studies are still needed to learn more about this new virus. To add to it, they stressed that the research was carried on in a healthier and younger population than the general population.
Though the conclusion of how long the immune system can hold against the prevalent pathogen has not been reached yet, the research shows that COVID-19 vaccines are safe, even for those who were already tested positive for the virus.
The Ohio Hospital Association said that the numbers of COVID-19 hospitalized reached fewer than 600 for the last three days. Ohio is vaccinating people aged 12 and older and now speeding up the use of 200,000 doses of Johnson & Johnson vaccines which expire on June 23.
As of June 7, more than 4.7 million Ohioans have received COVID-19 shots.
The Cleveland Clinic is a nonprofit multispecialty academic medical center that focuses on clinical and hospital care with research and education. Located in Cleveland, Ohio, the nonprofit was founded in 1921 by four renowned physicians and has pioneered many medical breakthroughs since then.